RaQualia Pharma Inc. (TYO:4579)
Japan flag Japan · Delayed Price · Currency is JPY
714.00
-29.00 (-3.90%)
Nov 18, 2026, 10:30 AM JST

RaQualia Pharma Income Statement

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4,0183,9793,1071,9012,9182,776
Revenue Growth
31.77%28.07%63.44%-34.85%5.12%150.77%
Cost of Revenue
645.78712625245231321
Gross Profit
3,3723,2672,4821,6562,6872,455
Selling, General & Admin
866.32893782615566615
Research & Development
1,6251,5991,7031,3721,2481,127
Amortization of Goodwill & Intangibles
285285203---
Operating Expenses
2,7832,7842,6951,9931,8201,747
Operating Income
588.75483-213-337867708
Interest Expense
-62.07-59-42-7-6-1
Interest & Investment Income
45.4126891322
Currency Exchange Gain (Loss)
30.35-40385243145
Other Non Operating Income (Expenses)
-26.761-13011-17-1
EBT Excluding Unusual Items
575.66411-339-272900873
Gain (Loss) on Sale of Investments
--4--3516
Asset Writedown
2626-23-223-10
Other Unusual Items
-----18-
Pretax Income
601.66437-358-294850879
Income Tax Expense
252.6816413729127124
Net Income
348.98273-495-323723755
Net Income to Common
348.98273-495-323723755
Net Income Growth
-----4.24%-
Shares Outstanding (Basic)
262422222121
Shares Outstanding (Diluted)
262422222121
Shares Change
12.57%11.14%0.16%2.97%0.05%0.10%
EPS (Basic)
13.6811.52-22.87-14.9534.4836.03
EPS (Diluted)
13.4911.36-22.87-14.9534.4736.03
EPS Growth
-----4.34%-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
--42184-9231,449274
Free Cash Flow Per Share
--17.503.88-42.7269.0613.06
Gross Margin
83.93%82.11%79.88%87.11%92.08%88.44%
Operating Margin
14.65%12.14%-6.86%-17.73%29.71%25.50%
Profit Margin
8.69%6.86%-15.93%-16.99%24.78%27.20%
Free Cash Flow Margin
--10.58%2.70%-48.55%49.66%9.87%
EBITDA
1,058970188-1621,014849
EBITDA Margin
26.34%24.38%6.05%-8.52%34.75%30.58%
D&A For EBITDA
469.71487401175147141
EBIT
588.75483-213-337867708
EBIT Margin
14.65%12.14%-6.86%-17.73%29.71%25.50%
Effective Tax Rate
42.00%37.53%--14.94%14.11%